Featured News
More News
SDRC member, Dr. Eric Appel, creates a new insulin formulation for better glucose control
Researchers have developed a way to combine insulin with a second hormone known as amylin, to create a two-in-one injection that could, if proven safe and effective in human trials, make it easier for diabetics to more effectively control their blood sugar levels.
SDRC New Member Spotlight: Dr. Danny Chou
“A game changer” is how SDRC’s newest member, Dr. Danny Chou describes the development of Smart Insulin, a type of insulin formulation that can maintain normal blood sugar levels without the accompanying risk of hypoglycemia.
SDRC member, Dr. Joyce Liao is director of the newly established Stanford Health Care Center for Optic Disc Drusen
As a bespectacled second-grader, Sam Hickman was undergoing an annual eye exam when his optometrist noticed that his optic nerves looked “lumpy-bumpy” — a telltale sign of optic disc drusen (ODD).
SDRC member, Dr. David Scheinker’s dashboard to estimate the COVID hospitalization rate at the county level
Input the number of COVID-19 cases, the rate at which they spread, and the impact of an intervention to estimate the number of people requiring hospitalization.
Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice
Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.